PATENT CLAIM ANALYSIS

Application Number: 16270837
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "494000"]

Abstract:
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 20):
The method of  claim 1 , wherein oral administration in the fasting state of said dosage form comprising a total dose of about the below-specified dose of ARBAC provides a pharmacokinetic profile defined as follows: Parameter 10 mg dose 15 mg dose 20 mg dose Tmax (hr) (median about 5 about 4.5 About 5 or mean) Cmax (ng/ml) about 77 about 100 About 142 AUC 0-inf  (ng \u00b7 h/ml) About 575 About 700 About 1090

Metadata:
- Claim Count in Document: 113.0
- Percentile: 99.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15146525', '15919422', '15048743', '15919436', '15132972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8443603731868988
- 35 USC 102 Novelty (BERT): 0.6512568761226942
- Combined Prediction Score: 0.8250500234804784
- Mean Citation Score: 576.303538
- Max Citation Score: 585.8544
- Similarity Product: 551.5091847318648

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test